Healthpeak Properties (NYSE:DOC) Hits New 1-Year High – Time to Buy?

Healthpeak Properties, Inc. (NYSE:DOC)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $21.91 and last traded at $21.8950, with a volume of 6078294 shares changing hands. The stock had previously closed at $21.55.

Analysts Set New Price Targets

Several research firms recently issued reports on DOC. JPMorgan Chase & Co. increased their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Scotiabank boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 27th. Royal Bank Of Canada boosted their price target on Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a report on Thursday, May 14th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Finally, Wells Fargo & Company increased their price objective on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Three research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $19.93.

Healthpeak Properties Stock Up 1.6%

The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $15.09 billion, a P/E ratio of 68.42, a PEG ratio of 3.36 and a beta of 1.05. The company has a fifty day moving average price of $19.15 and a 200-day moving average price of $17.71.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. During the same period in the prior year, the company earned $0.46 earnings per share. The firm’s revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, research analysts forecast that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which was paid on Friday, June 26th. Stockholders of record on Monday, June 15th were issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 5.6%. The ex-dividend date of this dividend was Monday, June 15th. Healthpeak Properties’s dividend payout ratio is 381.25%.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

Several large investors have recently bought and sold shares of the business. State Street Corp raised its stake in Healthpeak Properties by 1.8% during the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock worth $493,251,000 after buying an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its stake in shares of Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Healthpeak Properties by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock worth $312,959,000 after buying an additional 123,274 shares during the last quarter. Finally, Invesco Ltd. increased its holdings in shares of Healthpeak Properties by 9.9% in the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after buying an additional 1,648,012 shares during the last quarter. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.